Toxicology and Epidemiology: Improving the Science with a Framework for Combining Toxicological and Epidemiological Evidence to Establish Causal Inference
暂无分享,去创建一个
James A. Swenberg | Noel S. Weiss | Timothy P. Pastoor | H. Adami | D. Trichopoulos | N. Weiss | J. Swenberg | T. Pastoor | Dimitrios Trichopoulos | Hans-Olov Adami | C. Breckenridge | Lewis L. Smith | S. C. Berry | Sir Colin L. Berry | Charles B. Breckenridge
[1] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.
[2] J. Swenberg,et al. alpha 2-Urinary globulin-associated nephropathy as a mechanism of renal tubule cell carcinogenesis in male rats. , 1999, IARC scientific publications.
[3] Michael S Victoroff,et al. Evidence-based toxicology: a comprehensive framework for causation , 2005, Human & experimental toxicology.
[4] F. Speizer,et al. Cohort studies of fat intake and the risk of breast cancer--a pooled analysis. , 1996, The New England journal of medicine.
[5] Chien-Jen Chen,et al. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan , 1996, International journal of cancer.
[6] A. Zuckerman,et al. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.
[7] T. Pastoor,et al. Historical perspective of the cancer bioassay. , 2005, Scandinavian journal of work, environment & health.
[8] Ames,et al. Cohort studies of fat intake and the risk of breast cancer--a pooled analysis. , 2000 .
[9] Alan R. Boobis,et al. IPCS Framework for Analyzing the Relevance of a Cancer Mode of Action for Humans , 2006 .
[10] K. Popper,et al. The Logic of Scientific Discovery , 1960 .
[11] M Younes,et al. IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. , 2001, Regulatory toxicology and pharmacology : RTP.
[12] A. B. Hill. The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.
[13] A. Boobis,et al. The Key Events Dose-Response Framework: A Cross-Disciplinary Mode-of-Action Based Approach to Examining Dose-Response and Thresholds , 2009, Critical reviews in food science and nutrition.
[14] David Y. Lai,et al. PPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance , 2003 .
[15] James E Klaunig,et al. The Human Relevance of Information on Carcinogenic Modes of Action: Overview , 2003, Critical reviews in toxicology.
[16] James E Klaunig,et al. PPARalpha agonist-induced rodent tumors: modes of action and human relevance. , 2003, Critical reviews in toxicology.
[17] R. Kavet,et al. Future needs of occupational epidemiology of extremely low frequency electric and magnetic fields: review and recommendations , 2008, Occupational and Environmental Medicine.
[18] P. Pinsky,et al. Public Health Service study of Reye's syndrome and medications. Report of the main study. , 1987, JAMA.
[19] D. Weed. Weight of Evidence: A Review of Concept and Methods , 2005, Risk analysis : an official publication of the Society for Risk Analysis.
[20] J. Fraumeni,et al. Cancer epidemiology and prevention. , 2006 .
[21] M Susser,et al. The logic of Sir Karl Popper and the practice of epidemiology. , 1986, American journal of epidemiology.
[22] K Yamagiwa,et al. Experimental study of the pathogenesis of carcinoma , 1977, CA: a cancer journal for clinicians.
[23] Pagona Lagiou,et al. Causality in cancer epidemiology , 2005, European Journal of Epidemiology.
[24] E. Dybing,et al. Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis. Proceedings of a consensus conference. Lyon, France, 3-7 November 1997. , 1999, IARC scientific publications.
[25] R. Koch,et al. Die Aetiologie der Tuberkulose , 1932, Klinische Wochenschrift.
[26] A. Aitio,et al. Human Carcinogens So Far Identified , 1989, Japanese journal of cancer research : Gann.
[27] Kim Z. Travis,et al. A proposed framework for the integration of human and animal data in chemical risk assessment , 2008 .
[28] R. Sarid,et al. Virology, pathogenetic mechanisms, and associated diseases of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8). , 2002, Mayo Clinic proceedings.
[29] L. Haroun,et al. Identification of Chemicals Carcinogenic to Man , 1984, Toxicologic pathology.
[30] G. Williams,et al. Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation, and tumor promotion. , 1996, Pharmacology & therapeutics.
[31] Jennifer Seed,et al. Overview: Using Mode of Action and Life Stage Information to Evaluate the Human Relevance of Animal Toxicity Data , 2005, Critical reviews in toxicology.
[32] D. Brusick,et al. Atrazine and Breast Cancer: A Framework Assessment of the Toxicological and Epidemiological Evidence , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[33] H. Iwase,et al. [Breast cancer]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.
[34] Carolyn Vickers,et al. IPCS framework for analysing the relevance of a cancer mode of action for humans , 2006 .
[35] R. Koch,et al. Ueber den augenblicklichen Stand der bakteriologischen Choleradiagnose , 1893, Zeitschrift für Hygiene und Infektionskrankheiten.
[36] John D. Graham. The role of epidemiology in regulatory risk assessment : proceedings of the Conference on the Proper Role of Epidemiology in Risk Analysis, Boston, MA, U.S.A., 13-14 October 1994 , 1995 .
[37] Carl V Phillips,et al. Epidemiologic Perspectives & Innovations Open Access the Missed Lessons of Sir Austin Bradford Hill , 2004 .
[38] S. Greenland,et al. Causation and causal inference in epidemiology. , 2005, American journal of public health.
[39] Jennifer Seed,et al. A Framework for Human Relevance Analysis of Information on Carcinogenic Modes of Action , 2003, Critical reviews in toxicology.
[40] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.
[41] A. Feinstein,et al. New epidemiologic evidence confirming that bias does not explain the aspirin/Reye's syndrome association. , 1989, JAMA.
[42] B. Henderson,et al. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[43] Leeka Kheifets,et al. Occupational Electromagnetic Fields and Leukemia and Brain Cancer: An Update to Two Meta-Analyses , 2008, Journal of occupational and environmental medicine.
[44] Causality and the interpretation of epidemiologic evidence. , 2007, Environmental health perspectives.
[45] S. Pocock,et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration , 2007, Annals of Internal Medicine [serial online].
[46] R. Campbell,et al. Reye's syndrome and medication use. , 1982, JAMA.
[47] J. M. Tabuenca. TOXIC-ALLERGIC SYNDROME CAUSED BY INGESTION OF RAPESEED OIL DENATURED WITH ANILINE , 1981, The Lancet.
[48] D. Varma. HYDROGEN CYANIDE AND BHOPAL , 1989, The Lancet.
[49] K F WELLMANN,et al. [SMOKING AND HEALTH. ON THE REPORT OF THE ADVISORY COMMITTEE TO THE SURGEON GENERAL OF THE PUBLIC HEALTH SERVICE]. , 1964, Deutsche medizinische Wochenschrift.
[50] Education Welfare.,et al. Smoking and Health. Report of the Advisory Committee to the Surgeon General of the Public Health Service. , 1964 .